Search PubMed⌕ Search

Biomedical subjects

K R Kase

Publications and source records attributed to K R Kase.

41 records · Page 3Linked to original sources

Head scatter data for several linear accelerators (4-18 MV).

Measurements were made in air on the central axis of radiation beams from linear accelerators operating in the energy range from 4 to 18 MV, to determine the magnitude and source of head scattered radiation. Machines of several manufacturers were studied. The data indicate that, except for one unique collimator design, head scatter originates primarily in the flattening filter and is relatively independent of energy and machine.

Humans↗

Measurement of replacement factors for a parallel-plate chamber.

We have measured the replacement correction factors (Prepl) for a PTW/Markus parallel plate chamber at mean incident electron energies of 3.1, 4.4, 8.9, 13.0, 16.3, and 18.8 MeV. The factors are significantly different from unity at low energies.

Electrons↗

Determination of primary dose in 60Co gamma beam using a small attenuator.

A measurement technique previously proposed for determining dose from primary radiation has been tested using 60Co gamma rays. It is shown that the dose from primary radiation is reliably determined for field sizes of 10 X 10 and 20 X 20 cm2 at depths of 0.5, 5, and 10 cm in water. With further development this technique may be useful for verifying dose from primary radiation that may be calculated using a variety of methods.

Aluminum↗

Validity of transition-zone dosimetry at high atomic number interfaces in megavoltage photon beams.

Measurement of dose or dose perturbation factors at high atomic number interfaces are usually performed with a thin-window parallel-plate ion chamber. In a transition region, under nonequilibrium conditions, accuracy of ion chamber readings for the dose measurements has often been questioned. This paper critically analyzes the factors (stopping power ratio and charge collection) for the dose measurements at interfaces. Monte Carlo simulations were performed to investigate the secondary electron spectrum produced by photon beams and to calculate the stopping power ratios at the point of measurement. The validity of dose measurements was studied for the photon beams in the range of Co-60 gamma rays to 24-MV x rays at bone and lead interfaces with polystyrene, using thermoluminescent dosimeters, extrapolation chamber and several types of commercially available parallel-plate ion chambers. It is observed that for energies greater than 10 MV most parallel-plate chambers can be used to measure dose accurately. At lower energies, however significant differences between measured doses with different detectors were noticed. It is suggested that at high-Z interfaces and lower energies, the dose measurements should be performed with ultrathin-window parallel-plate ion chambers or extrapolation chambers.

Bone and Bones↗

Higher energy: is it necessary, is it worth the cost for radiation oncology?

The physical characteristics of the interactions of megavoltage photons and electrons with matter provide distinct advantages, relative to low-energy (orthovoltage) x rays, that lead to better radiation dose distributions in patients. Use of these high-energy radiations has resulted in better patient care, which has been reflected in improved radiation treatment outcome in recent years. But, as the desire for higher energy radiation beams increases, it becomes important to determine whether the physical characteristics that make megavoltage beams beneficial continue to provide a net advantage. It is demonstrated that, in fact, there is an energy range from 4 to 15 MV for photons and 4 to 20 MeV for electrons that is optimally suited for the treatment of cancer in humans. Radiation beams that exceed these maximum energies were found to add no advantage. This is because the costs (price of unit, installation, maintenance, shielding for neutron and photons) are not justified by either improved physical characteristics of the radiation (penetration, skin sparing, dose distribution) or treatment outcome. In fact, for photon beams some physical characteristics result in less desirable dose distributions, less accurate dosimetry, and increased safety problems as the energy increases for example, increasingly diffuse beam edges, loss of electron equilibrium, uncertainty in dose perturbations at interfaces, increased neutron contamination, and potential for higher personnel dose. The special features that make electron beams useful at lower energies, for example, skin sparing and small penetration, are lost at high energies. These physical factors are analyzed together with the economic factors related to radiation therapy patient care using megavoltage beams.

Cost-Benefit Analysis↗